Compare NCNA & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NCNA | RVYL |
|---|---|---|
| Founded | 1997 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 9.3M |
| IPO Year | 2017 | 2008 |
| Metric | NCNA | RVYL |
|---|---|---|
| Price | $2.01 | $5.60 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 28.4K | 10.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.34 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $55,998,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $297.49 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.03 | $0.14 |
| 52 Week High | $10.00 | $8.55 |
| Indicator | NCNA | RVYL |
|---|---|---|
| Relative Strength Index (RSI) | 38.45 | 50.74 |
| Support Level | $0.05 | $5.34 |
| Resistance Level | $2.27 | $6.10 |
| Average True Range (ATR) | 0.16 | 0.35 |
| MACD | 0.03 | -0.09 |
| Stochastic Oscillator | 27.03 | 35.35 |
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.